Evidence map›Paper›PMID 30669690›Full record

ReviewInternational journal of molecular sciences2019

Do Neural Stem Cells Have a Choice? Heterogenic Outcome of Cell Fate Acquisition in Different Injury Models.

Felix Beyer, Iria Samper Agrelo, Patrick Küry

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Autologous cord blood in children with cerebral palsy: a review.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Felix BeyerDepartment of Neurology, Medical Faculty, Heinrich-Heine-University, D-40225 Düsseldorf, Germany. felix.beyer@uni-duesseldorf.de.ORCID 0000-0002-3329-0249
Iria Samper AgreloDepartment of Neurology, Medical Faculty, Heinrich-Heine-University, D-40225 Düsseldorf, Germany. iria.samperagrelo@med.uni-duesseldorf.de.ORCID 0000-0003-4597-6157
Patrick KüryDepartment of Neurology, Medical Faculty, Heinrich-Heine-University, D-40225 Düsseldorf, Germany. kuery@uni-duesseldorf.de.ORCID 0000-0002-2654-1126

Funding

Research on myelin repair in the laboratory of P.K. was supported by the French societies ARSEP (Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques) and AFM (Association Française Contre les Myopathies), the Christiane and Claudia Hempel Foun DGF: grants KU1934/2-1, KU1934/5-1
6 · The paper itself

Abstract

The adult mammalian central nervous system (CNS) is generally considered as repair restricted organ with limited capacities to regenerate lost cells and to successfully integrate them into damaged nerve tracts. Despite the presence of endogenous immature cell types that can be activated upon injury or in disease cell replacement generally remains insufficient, undirected, or lost cell types are not properly generated. This limitation also accounts for the myelin repair capacity that still constitutes the default regenerative activity at least in inflammatory demyelinating conditions. Ever since the discovery of endogenous neural stem cells (NSCs) residing within specific niches of the adult brain, as well as the description of procedures to either isolate and propagate or artificially induce NSCs from various origins ex vivo, the field has been rejuvenated. Various sources of NSCs have been investigated and applied in current neuropathological paradigms aiming at the replacement of lost cells and the restoration of functionality based on successful integration. Whereas directing and supporting stem cells residing in brain niches constitutes one possible approach many investigations addressed their potential upon transplantation. Given the heterogeneity of these studies related to the nature of grafted cells, the local CNS environment, and applied implantation procedures we here set out to review and compare their applied protocols in order to evaluate rate-limiting parameters. Based on our compilation, we conclude that in healthy CNS tissue region specific cues dominate cell fate decisions. However, although increasing evidence points to the capacity of transplanted NSCs to reflect the regenerative need of an injury environment, a still heterogenic picture emerges when analyzing transplantation outcomes in injury or disease models. These are likely due to methodological differences despite preserved injury environments. Based on this meta-analysis, we suggest future NSC transplantation experiments to be conducted in a more comparable way to previous studies and that subsequent analyses must emphasize regional heterogeneity such as accounting for differences in gray versus white matter.

Indexed as

AnimalsCell DifferentiationDisease Models, AnimalHumansNeural Stem CellsNeuronsSpinal Cord InjuriesStem Cell TransplantationTrauma, Nervous SystemTreatment OutcomeCNS injurydiseaseinjury environmentneural stem cellregenerationregional heterogeneitysubgranular zonesubventricular zonetherapytransplantation

Identifiers

PMID30669690
PMCPMC6359747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.